DR-70 tumor marker assay data

Data from an ongoing Canadian trial with AMDD's DR-70 tumor marker test for all types of lung cancer in 237 patients with the disease and 244 controls showed that the test could help predict patient outcome.

For all lung cancer patients enrolled, a DR-70 antigen reading of <7.25 correlated with a median survival rate of 55 weeks, whereas patients with a DR-70 reading of 7.25-12 had a median survival rate of 30 weeks. Those with a reading of >12 had the lowest survival rate - 17 weeks. ...